Good Distribution Practice
Supply-chain integrity, storage, and cold-chain control.
What this page does not claim
Educational orientation — not a determination of regulatory applicability, compliance, validation scope, or organizational approval.
WHAT IT GOVERNS
Good Distribution Practice governs the storage and transport of medicinal products through the supply chain (EU GDP 2013/C 343/01 and equivalents) — the part of the lifecycle after a product leaves the manufacturer and before it reaches the patient. Its job is to preserve the quality and integrity built at manufacture and to keep falsified medicines out of the legitimate chain.
WHY IT MATTERS
A perfectly manufactured product can still be ruined in distribution — a broken cold chain, a temperature excursion, or a falsified-medicine infiltration undoes everything upstream. GDP is where supply integrity is defended, and its failures translate directly into degraded product reaching patients or shortages when compliant supply is disrupted.
KEY FOCUS AREAS
Temperature & cold-chain control
Qualified storage and transport with mapped temperatures, monitored conditions, and defined limits — so cold-chain and ambient products stay within their labelled storage range end to end.
Qualification of suppliers & customers
Trading only with authorised suppliers and customers, verifying licences, and applying due diligence that keeps the distribution network legitimate.
Transport & shipping validation
Validated shipping lanes and packaging that hold conditions through the real-world transport a product will actually experience, including worst-case seasons and routes.
Falsified-medicine safeguards
Controls against falsified medicines entering the supply chain — verification, tamper-evidence, and handling of suspected falsifications.
STANDARDS SPEQ DECODES · 12
Open the full library →WHAT INSPECTORS LOOK AT
- Temperature mapping of storage areas and vehicles
- Management of excursions — assessment, decision, and product disposition
- Handling of returns, recalls, and suspected falsified products
- Wholesale distribution authorization and qualification of trading partners
RELATED DISCIPLINES
SECTORS THAT OPERATE UNDER GDP
GDP: frequently asked questions
Reference answers on Good Distribution Practice — what it governs, what regulations define it, and what it requires.
What is Good Distribution Practice (GDP)?
GDP governs the storage and transport of medicinal products through the supply chain — the part of the lifecycle after a product leaves the manufacturer and before it reaches the patient. Its job is to preserve the quality and integrity built at manufacture and to keep falsified medicines out of the legitimate chain.
What guideline governs GDP in the EU?
EU distribution is governed by the Guidelines on Good Distribution Practice of medicinal products for human use, 2013/C 343/01. Equivalent standards are published by other authorities. They cover temperature control, qualification of suppliers and customers, transport, and the handling of returns, recalls, and suspected falsifications.
What does GDP require for cold-chain products?
GDP requires qualified storage and transport with mapped temperatures, monitored conditions, and defined limits, so cold-chain and ambient products stay within their labelled storage range end to end. Shipping lanes and packaging must be validated against the real-world transport a product will experience, including worst-case seasons and routes.